论文部分内容阅读
无论在国际、国内,男性、女性,也无论在城市或是农村,肺癌都是死亡率最高的恶性肿瘤,其死亡的人数比排名第2~5位的恶性肿瘤总和还多。在医学日新月异的20世纪末至21世纪初,肺癌在治疗手段方面仍没有突破性的进展。肺癌患者总的5年生存率仍停留在1 5%左右,早期(Ⅰ期)肺癌患者的,5年生存率为80%。有研究证实,经过筛查检测出来,并在1个月内进行手术切除的早期肺
Lung cancer is the most highly malignant cancer both in the world and in China, both men and women, both in urban areas and in rural areas. The number of deaths is even higher than the total number of malignant tumors ranked No. 2 to No. 5. In the rapid evolution of medicine from the late 20th century to the beginning of 21st century, there is still no breakthrough in the treatment of lung cancer. The overall 5-year survival rate of patients with lung cancer remains at about 15%. The 5-year survival rate of patients with early stage lung cancer (I stage) is 80%. Some studies have confirmed that after screening detected and within 1 month of surgical resection of the early lung